Medicare Enrolled
Dr. Kishore Sehgal, M.D.
Optician · Hemet, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sehgal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sehgal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sehgal
Dr. Kishore Sehgal is an optician specialist in Hemet, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sehgal performed 353,544 Medicare services across 4,223 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sehgal received a total of $13,335 from 88 pharmaceutical and/or device companies across 540 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sehgal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in CA
$13,335 industry payments
Medicare Practice Summary
Medicare Utilization ↗353,544
Medicare services
Top 0% in CA for optician
4,223
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~17,677 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
142,500 | $1 | $2 |
| Nivolumab injection (Opdivo) | 22,960 | $24 | $32 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
20,880 | $38 | $61 |
| Pembrolizumab injection (Keytruda) | 19,800 | $43 | $57 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
17,410 | $6 | $14 |
| Paclitaxel protein-bound particle injection An injection of paclitaxel formulated as protein-bound particles. This code specifies the administration of the medication measured in milligrams. |
17,200 | $10 | $15 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
16,200 | $0 | $3 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
11,700 | $0 | $0 |
| Injection, immune globulin (bivigam), 500 mg | 9,180 | $57 | $80 |
| Injection, heparin sodium, (heparin lock flush), per 10 units | 8,950 | $0 | $0 |
| Paclitaxel chemotherapy injection | 8,839 | $0 | $1 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
8,187 | $4 | $55 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
7,392 | $26 | $41 |
| Denosumab injection (Prolia/Xgeva) | 5,340 | $17 | $22 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
5,100 | $6 | $15 |
| Anti-nausea injection (aprepitant) | 4,810 | $1 | $4 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
4,708 | $0 | $0 |
| Injection, granisetron, extended-release, 0.1 mg | 3,800 | $4 | $7 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,680 | $1 | $13 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,181 | $8 | $11 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,709 | $95 | $131 |
| Rituximab-arrx biosimilar injection, 10 mg An injection of rituximab-arrx, a biosimilar medication, administered in a 10 mg dose. |
1,650 | $35 | $95 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,514 | $3 | $3 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
1,407 | $13 | $16 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,017 | $12 | $15 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
741 | $111 | $139 |
| Injection, leucovorin calcium, per 50 mg | 730 | $3 | $13 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
464 | $55 | $69 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
425 | $60 | $77 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
380 | $6 | $12 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
376 | $1 | $2 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
358 | $2 | $7 |
| Pegfilgrastim-fpgk biosimilar injection, 0.5 mg An injection of pegfilgrastim-fpgk, a biosimilar medication, administered at a dose of 0.5 mg. |
348 | $274 | $384 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
319 | $17 | $21 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
251 | $1 | $5 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
239 | $2 | $7 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
190 | $3 | $8 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
189 | $54 | $68 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
181 | $22 | $29 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
137 | $24 | $30 |
| New patient office visit, complex (60-74 min) | 111 | $163 | $225 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
99 | $24 | $30 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 84 | $9 | $14 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
74 | $21 | $28 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
74 | $1 | $1 |
| Injection, alteplase recombinant, 1 mg | 62 | $68 | $101 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
60 | $29 | $36 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
57 | $47 | $59 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
54 | $81 | $103 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
45 | $30 | $39 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
43 | $127 | $185 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
41 | $11 | $13 |
| Refilling and maintenance of portable pump This service involves refilling and performing maintenance on a portable pump. |
41 | $107 | $134 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
40 | $2 | $3 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 37 | $313 | $615 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
35 | $63 | $79 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
26 | $17 | $21 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
25 | $148 | $190 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $71 | $93 |
| Central venous tube declotting A procedure to clear a blockage or clot from a central venous catheter to restore its function. |
22 | $27 | $36 |
| Intravenous chemotherapy injection Chemotherapy medication is administered directly into a vein using a push technique. This method involves injecting the drug through a needle or catheter already placed in the vein. |
17 | $76 | $108 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
16 | $1 | $3 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
15 | $28 | $34 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
40.8% high complexity
57.4% medium
1.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,335
Total received (2018-2024)
Avg $1,905/year across 7 years
Top 11% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
540
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,500 (86.2%)
Other
Charitable contributions, space rental, and other categories
$1,403 (10.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$433 (3.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,142
2023
$2,915
2022
$2,363
2021
$1,778
2020
$397
2019
$1,512
2018
$1,229
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,403
Janssen Biotech, Inc.
$179
AstraZeneca Pharmaceuticals LP
$163
ABBVIE INC.
$136
Merck Sharp & Dohme LLC
$105
Karyopharm Therapeutics Inc.
$95
E.R. Squibb & Sons, L.L.C.
$89
PFIZER INC.
$77
Incyte Corporation
$77
Celgene Corporation
$64
Daiichi Sankyo Inc.
$60
SOBI, INC
$59
ARRAY BIOPHARMA INC
$54
Astellas Pharma US Inc
$53
Coherus Biosciences Inc.
$45
SpringWorks Therapeutics, Inc.
$45
GENZYME CORPORATION
$41
Dendreon Pharmaceuticals LLC
$35
Alexion Pharmaceuticals, Inc.
$35
Regeneron Healthcare Solutions, Inc.
$31
Tempus AI, Inc
$27
Takeda Pharmaceuticals U.S.A., Inc.
$25
Adaptive Biotechnologies Corporation
$25
Ipsen Biopharmaceuticals, Inc
$24
Immunocore Limited
$24
Gilead Sciences, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$22
Blueprint Medicines Corporation
$21
PUMA BIOTECHNOLOGY, INC.
$20
Octapharma USA, Inc.
$19
GlaxoSmithKline, LLC.
$18
EMD Serono, Inc.
$17
Lilly USA, LLC
$17
Agios Pharmaceuticals, Inc.
$17
Top 3 companies account for 55.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,088
Janssen Biotech, Inc.
$1,350
AstraZeneca Pharmaceuticals LP
$909
Seagen Inc.
$473
PFIZER INC.
$425
Amgen Inc.
$372
E.R. Squibb & Sons, L.L.C.
$345
Daiichi Sankyo Inc.
$324
Seattle Genetics, Inc.
$306
Merck Sharp & Dohme LLC
$294
Astellas Pharma US Inc
$275
Incyte Corporation
$271
GENZYME CORPORATION
$269
Takeda Pharmaceuticals U.S.A., Inc.
$253
Celgene Corporation
$191
JAZZ PHARMACEUTICALS INC.
$180
Genentech USA, Inc.
$168
Gilead Sciences, Inc.
$166
Epizyme, Inc.,
$165
Karyopharm Therapeutics Inc.
$165
ABBVIE INC.
$155
Pharmacyclics LLC, An AbbVie Company
$153
GlaxoSmithKline, LLC.
$150
Lilly USA, LLC
$144
Coherus Biosciences Inc.
$142
Bayer HealthCare Pharmaceuticals Inc.
$137
Merck Sharp & Dohme Corporation
$134
Dendreon Pharmaceuticals LLC
$128
ARRAY BIOPHARMA INC
$128
Alexion Pharmaceuticals, Inc.
$128
Rigel Pharmaceuticals, Inc.
$126
EISAI INC.
$125
AbbVie Inc.
$120
Pharmacyclics LLC, an AbbVie Company
$119
Regeneron Healthcare Solutions, Inc.
$114
SOBI, INC
$109
Stemline Therapeutics Inc.
$105
Intuitive Surgical, Inc.
$105
Ipsen Biopharmaceuticals, Inc
$104
BeiGene USA, Inc.
$98
Eisai Inc.
$93
Taiho Oncology, Inc.
$80
Sobi, Inc
$77
Adaptive Biotechnologies Corporation
$74
ACCORD HEALTHCARE, INC.
$73
Blueprint Medicines Corporation
$67
Octapharma USA, Inc.
$65
Pharmacosmos Therapeutics Inc.
$54
Organon LLC
$53
Puma Biotechnology, Inc.
$50
EUSA Pharma (US) LLC
$48
Mylan Institutional Inc.
$48
AMAG Pharmaceuticals, Inc.
$46
TG THERAPEUTICS, INC.
$46
SpringWorks Therapeutics, Inc.
$45
SERVIER PHARMACEUTICALS LLC
$44
AbbVie, Inc.
$43
Kite Pharma, Inc.
$43
Teva Pharmaceuticals USA, Inc.
$41
Deciphera Pharmaceuticals Inc.
$40
EMD Serono, Inc.
$40
Janssen Pharmaceuticals, Inc
$39
Mirati Therapeutics, Inc.
$38
Spectrum Pharmaceuticals Inc.
$36
Myovant Sciences Inc.
$35
Agios Pharmaceuticals, Inc.
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
TAIHO ONCOLOGY, INC.
$31
Aveo Pharmaceuticals, Inc.
$27
Tempus AI, Inc
$27
Apellis Pharmaceuticals, Inc.
$25
Immunocore Limited
$24
SANOFI-AVENTIS U.S. LLC
$23
MorphoSys, US Inc.
$23
Aurobindo Pharma USA, Inc.
$23
Bayer Healthcare Pharmaceuticals Inc.
$22
RECORDATI_RARE_DISEASES_INC.
$21
PUMA BIOTECHNOLOGY, INC.
$20
Sirtex Medical Inc
$20
Exelixis Inc.
$20
Verity Pharmaceuticals Inc.
$19
Medtronic USA, Inc.
$18
Foundation Medicine, Inc.
$17
BTG International, Inc.
$17
Acrotech Biopharma Inc.
$17
Secura Bio, Inc.
$16
Acrotech Biopharma LLC
$16
MAYNE PHARMA INC.
$13
Top 3 companies account for 32.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALUNBRIG · AVYCAZ · AYVAKIT · Abraxane · Alecensa · Aliqopa · BAVENCIO · BELEODAQ · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CALQUENCE · CAMCEVI · CARVYKTI · CHANTIX · COSELA · CROFAB · CYRAMZA · Cabometyx · DALVANCE · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELAHERE · ELIQUIS · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Empaveli · Enhertu · Erleada · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Farydak · Folotyn · GAMIFANT · GAZYVA · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · KYPHON Balloon Kyphoplasty · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LOQTORZI · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Ogivri · Onivyde · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SYLVANT · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trelstar · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VELCADE · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · Venclexta · Vyloy · WELIREG · XALKORI · XARELTO · XPOVIO · XTANDI · Xofigo · Xtandi · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
88
Per 100K population
3.6
County median income
$89,672
Nearest hospital
HEMET GLOBAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sehgal is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with low-engagement industry engagement in the top 11% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sehgal experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Sehgal performed 142,500 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sehgal receive payments from pharmaceutical companies?
Yes. Dr. Sehgal received a total of $13,335 from 88 companies across 540 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sehgal's costs compare to other opticians in Hemet?
Dr. Sehgal's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sehgal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Hemet
Browse opticians in Hemet ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology